What Key Diagnostic Features Should Practitioners Evaluate Using Skin Testing Equipment To Differentiate Generalized Vitiligo From Post-Inflammatory Hypopigmentation Or Chemical Leukoderma? Key Clues For Accurate Diagnosis

The key distinction is complete versus partial pigment loss. Practitioners should combine lesion morphology, distribution, exposure and inflammation history, and examination under a UVA/Wood’s lamp. Vitiligo usually shows sharply bordered, bright depigmented macules with a characteristic distribution, whereas post-inflammatory hypopigmentation is usually irregular and retains some melanin; chemical leukoderma may show complete depigmentation but is suggested by a relevant chemical exposure and contact-pattern distribution.

Wood’s illumination clarifies whether pigment is absent or merely reduced, but it does not independently distinguish vitiligo from chemical leukoderma. The final assessment requires correlation with lesion pattern, symptoms, history, and evidence of prior inflammation or chemical exposure.

First Determine Whether Pigment Is Absent or Reduced

Evaluate the appearance in normal lighting

Vitiligo typically produces uniform milky-white or chalk-white macules and patches with sharply defined borders. Lesions commonly involve acral sites, periorificial areas, hands, feet, and extensor surfaces over joints.

Post-inflammatory hypopigmentation more often appears as paler-than-normal skin rather than completely white skin. Its borders may be indistinct, and the surface can show residual scale, textural change, or evidence of the preceding dermatitis or inflammatory disease.

Chemical leukoderma can produce complete depigmentation and therefore may closely resemble vitiligo. The most useful initial clues are the location, timing, and pattern of exposure, particularly contact with cosmetics, hair products, adhesives, rubber, industrial chemicals, or topical medications.

Use UVA or Wood’s illumination

A Wood’s lamp or comparable diagnostic system operating in the UVA range—commonly around 365 nm within the 320–400 nm spectrum—can increase contrast between normal and affected skin.

In vitiligo, areas of complete pigment loss typically become more conspicuous and sharply demarcated, often appearing bright blue-white compared with surrounding skin. This is especially useful for subtle lesions, sun-protected sites, and patients with darker complexions.

Post-inflammatory hypopigmentation generally shows less intense contrast and more residual or uneven pigmentation because melanocytes or melanin are reduced rather than entirely absent.

Interpret fluorescence carefully

Some vitiligo lesions may show increased fluorescence related to altered pteridine or biopterin metabolites. However, fluorescence is an adjunctive observation, not a standalone diagnostic test.

A bright Wood’s-lamp response supports the presence of marked depigmentation, but it does not by itself establish autoimmune vitiligo. Chemical leukoderma and other causes of complete pigment loss can also fluoresce prominently.

Identify the Pattern That Supports Vitiligo

Look for symmetry and typical sites

Generalized vitiligo often has a bilateral or symmetrical distribution, involving comparable areas on both sides of the body. Common sites include the hands, wrists, elbows, knees, ankles, eyelids, lips, and other periorificial or extensor regions.

The distribution is not required to be perfectly symmetrical, particularly early in the disease. Nevertheless, symmetry and involvement of characteristic sites strengthen the clinical impression of vitiligo.

Examine the lesion margins

Vitiligo commonly has smooth, sharply demarcated borders. A convex or expanding margin may indicate active spread, although border shape alone is not diagnostic.

Mixed borders, irregular mottling, and gradual transitions into surrounding skin favor post-inflammatory hypopigmentation or another acquired pigmentary disorder.

Check for additional vitiligo clues

Practitioners should document:

Leukotrichia, or whitening of hairs within a lesion.
New lesions at sites of friction, trauma, or pressure, known as a possible Koebner phenomenon.
Multiple lesions with similar morphology across typical body sites.
Periorificial involvement, including the lips and eyelids.
Evidence that lesions are enlarging or new lesions are developing.

These findings support vitiligo but should be interpreted alongside the exposure and inflammation history.

Distinguish Post-Inflammatory Hypopigmentation

Search for a preceding inflammatory condition

Ask whether the area previously had eczema, psoriasis, lupus, infection, injury, or another inflammatory eruption. Patients may recall itching, redness, scale, pain, crusting, or treatment before the color change appeared.

The temporal relationship is important: post-inflammatory hypopigmentation follows the original eruption and often remains localized to its prior distribution.

Assess residual pigment and surface changes

Post-inflammatory lesions commonly contain uneven residual melanin, producing mottled or patchy hypopigmentation rather than a uniform white appearance. Mild scale, altered texture, or residual inflammation may also remain.

Under Wood’s illumination, this incomplete pigment reduction usually produces less striking enhancement than fully depigmented vitiligo. The test can clarify the degree of pigment loss but cannot replace examination of the skin surface.

Consider the broader distribution

A single irregular patch at the site of a prior dermatitis is less typical of generalized vitiligo. Multiple lesions that correspond to previous inflammatory areas also favor a post-inflammatory process.

If the diagnosis remains uncertain, practitioners should reassess for active inflammation, scale, infection, or other causes of hypopigmentation rather than labeling every pale lesion as vitiligo.

Distinguish Chemical Leukoderma

Obtain a detailed exposure history

Chemical leukoderma should be considered when depigmentation follows exposure to a potentially melanocytotoxic substance. Relevant exposures may include:

Personal-care and cosmetic products.
Hair dyes and bleaching products.
Adhesives, rubber, and occupational chemicals.
Topical medications or repeated skin applications.
Products used on the face, hands, or other exposed contact areas.

The timing of onset and whether lesions appeared at sites of direct contact are often more informative than the Wood’s-lamp appearance.

Evaluate the contact pattern

Chemical leukoderma may show geometric, localized, or exposure-related lesions, particularly at repeated contact sites. It can also extend beyond the original exposure area or resemble vitiligo clinically.

Therefore, a contact distribution is suggestive rather than conclusive. Some chemical exposures may trigger or unmask a vitiligo-like process, so practitioners should document both the exposure pattern and any lesions appearing at unrelated typical vitiligo sites.

Compare exposed and unexposed skin

Inspect areas that were exposed to the suspected substance and comparable areas that were not. This comparison can reveal whether depigmentation is limited to contact sites or is part of a more generalized pattern.

A Wood’s lamp confirms the visibility and completeness of pigment loss, but history and distribution are essential for separating chemical leukoderma from idiopathic or autoimmune vitiligo.

Use Skin Testing Equipment as an Adjunct

Standardize the examination

For reliable comparison, examine lesions under consistent conditions:

Inspect the skin in ordinary lighting.
Remove reflective products or makeup when possible.
Use the UVA/Wood’s lamp in a suitably darkened setting.
Compare the lesion with adjacent normal skin.
Document the borders, intensity, symmetry, and distribution.
Record findings photographically when appropriate.

This approach reduces the risk of mistaking lighting differences, tanning, or surface scale for true depigmentation.

Map subtle lesions

Diagnostic illumination is particularly useful for detecting lesions that are difficult to see in ambient light. It can help identify:

Early or small vitiligo macules.
Lesions on sun-protected areas.
Subtle pigment loss in darker skin tones.
The true margins of a clinically indistinct patch.
Areas of mixed pigmentation that require further evaluation.

The result should be recorded as a pattern of complete depigmentation, partial hypopigmentation, or mixed change, rather than simply “positive” or “negative.”

Integrate the result with clinical information

The strongest assessment comes from agreement among three domains:

Morphology: sharply demarcated white lesions versus irregular pale patches.
Distribution: symmetric typical sites versus prior inflammation or chemical contact.
Optical findings: strong contrast indicating marked depigmentation versus less pronounced enhancement suggesting residual pigment.

No single observation should be treated as definitive when the clinical pattern is contradictory.

Understanding the Trade-offs

Wood’s illumination is not a definitive etiologic test

Wood’s-lamp examination can show how much pigment has been lost, but it generally cannot determine whether complete depigmentation is caused by vitiligo, chemical leukoderma, or another depigmenting disorder.

It should be viewed as a contrast-enhancing examination tool, not a substitute for history, physical examination, or specialist assessment.

Fluorescence can be overinterpreted

Pteridine or biopterin-related fluorescence may support the assessment of vitiligo, but its intensity can vary with lesion activity, equipment, ambient conditions, and the observer’s technique. It should not be presented as a unique biochemical signature that independently confirms the diagnosis.

Inflammation and treatment can obscure the pattern

Recent eczema, psoriasis, lupus, infection, or topical treatment may alter both the visible lesion and its response to illumination. When the skin is actively inflamed or recently treated, reassessment after the acute process has settled may provide a more reliable pattern.

Chemical exposure may coexist with vitiligo

A patient can have both a relevant chemical exposure and generalized vitiligo. Practitioners should avoid assuming that a contact history explains every lesion, particularly when depigmentation is symmetric or involves non-contact, periorificial, acral, or extensor sites.

How to Apply This to the Examination

Use the equipment to answer a specific clinical question: Is the pigment completely absent, and does the overall pattern support vitiligo, prior inflammation, or chemical contact?

If your primary focus is identifying generalized vitiligo: Look for sharply demarcated, uniform depigmentation with strong UVA contrast, symmetry, typical acral or periorificial involvement, leukotrichia, and lesions at multiple characteristic sites.
If your primary focus is identifying post-inflammatory hypopigmentation: Look for a preceding inflammatory eruption, irregular borders, residual or mottled pigment, scale or texture change, and weaker or uneven Wood’s-lamp contrast.
If your primary focus is identifying chemical leukoderma: Obtain a detailed exposure history and compare the lesion distribution with contact sites, recognizing that complete depigmentation may look similar to vitiligo under UVA illumination.
If your primary focus is avoiding misdiagnosis: Treat Wood’s-lamp findings as supportive evidence and document morphology, distribution, prior inflammation, exposure, and lesion evolution before selecting a treatment plan.

A disciplined combination of clinical pattern recognition and standardized UVA examination provides the clearest, safest basis for distinguishing these pigmentary disorders.

Summary Table:

Condition	Pigment Loss	Border	Distribution	Wood's Lamp	Key History
Vitiligo	Complete, uniform	Sharply defined	Symmetric, acral, periorificial	Bright blue-white, strong contrast	Autoimmune, koebner, leukotrichia
Post-inflammatory hypopigmentation	Partial, mottled	Indistinct	Localized to prior inflammation	Less intense, uneven	Preceding dermatitis, scale, texture change
Chemical leukoderma	Complete, can be uniform	Variable	Contact pattern, geometric	May be bright	Exposure to melanocytotoxic chemicals

Need expert guidance on selecting the right skin testing equipment? At BELIS, we provide professional-grade diagnostic devices trusted by clinics and premium salons worldwide. Our advanced skin testers accurately assess pigment loss, aiding in the differential diagnosis of vitiligo, post-inflammatory hypopigmentation, and chemical leukoderma. Whether you're a clinic expanding your aesthetic offerings or a distributor seeking high-margin products, we offer OEM/ODM support, certifications, and reliable supply. Contact our specialists today to elevate your practice — Get in touch!